关注
Dr. Bharti Mangla
Dr. Bharti Mangla
Delhi Pharmaceutical Sciences and Research University
在 dpsru.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nanostructured lipid carriers for oral bioavailability enhancement of exemestane: formulation design, in vitro, ex vivo, and in vivo studies
A Singh, YR Neupane, B Mangla, K Kohli
Journal of pharmaceutical sciences 108 (10), 3382-3395, 2019
762019
PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: In vitro and in vivo assessment
A Singh, YR Neupane, S Shafi, B Mangla, K Kohli
Journal of Molecular Liquids 303, 112649, 2020
472020
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials
B Mangla, S Javed, MH Sultan, P Kumar, K Kohli, A Najmi, HA Alhazmi, ...
Phytotherapy Research 35 (10), 5440-5458, 2021
412021
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment
NK Soni, LJ Sonali, A Singh, B Mangla, YR Neupane, K Kohli
Nanotechnology 31 (47), 475101, 2020
302020
Combination of natural agent with synthetic drug for the breast cancer therapy
B Mangla, K Kohli
Int J Drug Dev Res 10 (10), 22-26, 2018
292018
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies
B Mangla, YR Neupane, A Singh, P Kumar, S Shafi, K Kohli
Nanomedicine 15 (26), 2563-2583, 2020
282020
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach
B Mangla, YR Neupane, A Singh, K Kohli
Medical Hypotheses 132, 109379, 2019
222019
Graphene-based biosensors for disease theranostics: Development, applications, and recent advancements
HA Alhazmi, W Ahsan, B Mangla, S Javed, MZ Hassan, M Asmari, ...
Nanotechnology Reviews 11 (1), 96-116, 2021
202021
Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations
B Mangla, S Beg, O Alam, W Ahsan, A Haque, KS Patel, WH Almalki, ...
Arabian Journal of Chemistry 13 (11), 7909-7920, 2020
202020
Quercetin loaded silver nanoparticles in hydrogel matrices for diabetic wound healing
R Badhwar, B Mangla, YR Neupane, K Khanna, H Popli
Nanotechnology 32 (50), 505102, 2021
182021
Vicissitudes of liquid crystals for solubility enhancement of poorly soluble drugs
A Shoaib, B Mangla, S Javed, MH Sultan, SS Alqahtani, F Shakeel
Journal of Molecular Liquids 321, 114924, 2021
152021
Recent Advancements in the diagnosis, prevention, and prospective drug therapy of COVID-19
W Ahsan, HA Alhazmi, KS Patel, B Mangla, M Al Bratty, S Javed, A Najmi, ...
Frontiers in public health 8, 384, 2020
132020
Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug …
S Javed, B Mangla, Y Almoshari, MH Sultan, W Ahsan
Nanotechnology Reviews 11 (1), 1744-1777, 2022
122022
Reassessment of therapeutic applications of carbon nanotubes: A majestic and futuristic drug carrier
B Mangla, S Javed, K Kohli, A Ahsan, W Ahsan
Critical Reviews™ in Therapeutic Drug Carrier Systems 37 (4), 2020
122020
PEGylated nanoliposomes potentiated oral combination therapy for effective cancer treatment
A Singh, YR Neupane, B Mangla, S Shafi, K Kohli
Current Drug Delivery 17 (9), 728-735, 2020
92020
Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an …
B Mangla, O Alam, RA Rub, M Iqbal, A Singh, KS Patel, K Kohli
Journal of Chromatography B 1152, 122260, 2020
92020
Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System
Mohit, P Kumar, P Solanki, B Mangla, G Aggarwal
Journal of Pharmaceutical Innovation, 1-13, 2022
82022
Nanocarriers-assisted needle-free vaccine delivery through oral and intranasal transmucosal routes: A novel therapeutic conduit
B Mangla, S Javed, MH Sultan, W Ahsan, G Aggarwal, K Kohli
Frontiers in pharmacology 12, 757761, 2022
62022
Gefitinib: an updated review of its role in the cancer management, its nanotechnological interventions, recent patents and clinical trials
P Kumar, B Mangla, S Javed, W Ahsan, P Musyuni, A Ahsan, G Aggarwal
Recent Patents on Anti-Cancer Drug Discovery 18 (4), 448-469, 2023
52023
Design-of-Experiments (DoE)-Assisted Fabrication of Quercetin-Loaded Nanoemulgel and Its Evaluation against Human Skin Cancer Cell Lines
A Chitkara, B Mangla, P Kumar, S Javed, W Ahsan, H Popli
Pharmaceutics 14 (11), 2517, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20